Quarterly report pursuant to Section 13 or 15(d)

Note 22 - Subsequent events

v3.20.2
Note 22 - Subsequent events
9 Months Ended
Sep. 30, 2020
Notes  
Note 22 - Subsequent events

Note 22 – Subsequent events

 

On October 28, 2020, Mentor received $31,000 for its 80% interest in any commercial opportunities resulting from a study performed by Dr. Mandelkorn. Mentor had provided $30,000 of funding for the study, see Note 1.

 

On October 28, 2020, the $50,000 convertible note receivable from NeuCourt, originally maturing October 31, 2020, was amended to extend the maturity date to October 31, 2022. As consideration for the extension of the maturity date for the $50,000 note plus accrued interest of $5,132, a warrant to purchase up to 52,500 shares of NeuCourt common stock at $0.02 per share was issued to Mentor, see Note 7.

 

On November 4, 2020, Mentor’s Motion for Summary Adjudication was granted as to several causes of action against G FarmaLabs Limited and guarantors Atanachi Gonzalez and Nicole Gonzalez in the Superior Court California for the County of Marin. The Court found that G FarmaLabs Limited had breached its obligations under both promissory notes and that each of Mr. Gonzalez and Ms. Gonzalez owed duties to Mentor and Mentor Partner I as guarantors of those same promissory notes.